Late Abstract Submission

DEADLINE: 24th APRIL 2023 at 23:59 CET

Instructions to authors
Carefully read the guidelines before submitting your late abstract, find the guidelines here.
Upon submission, a confirmation email will be sent to the submitter’s email address. If you do not receive the confirmation e-mail, please do not submit the late abstract again. Instead, please contact the Scientific Secretariat abstract@eaaci.org for advice.

Declaration of conflict of interest
EAACI is committed to ensuring the integrity of scientific, educational, and research programmes. Late abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.

Personal Page
When entering the abstract submission system for the first time, you will be asked to create a MyEAACI account (if you don’t have one already). Through your MyEAACI account you will be able to access your personal page to submit one or several late abstracts. You can edit your late abstracts until the submission deadline on Monday 24th of April 2023, 23:59 CET.

Late abstract language and length
Late abstracts and presentations must be written in English. The maximum length allowed for a late abstract is 2500 characters (approximately 350 words) including blank spaces. The abstract title, the author(s) or names of institutions are not included in the count of 2500 characters.

Consent for publication of individual patient data – applies to late abstracts with identifiable patient
For the publication of a late abstract that contains identifiable information about patients, it is necessary that patients have given consent for the research to be published. For all late abstracts that include identifiable patient details (e.g. gender, age, illness, location) or images, written informed consent for the publication of these must be obtained from the patient (or their parent or legal guardian).
It is the author’s responsibility to obtain written informed consent for publication of clinical details and/or clinical images from the patient/parent/guardian/relative of the patient. A respective statement needs to be included in the late abstract text.

Duplication of publications
Unpublished abstracts that have been presented at a different scientific meeting within a 12 months period prior to EAACI Hybrid Congress 2023, provided they contain updated/additional data, can be submitted and will be considered for presentation. Abstracts submitted for publication or to a scientific meeting, but are pending acceptance, can be submitted without restrictions. However, once the abstract has been accepted by EAACI it is automatically subject to the EAACI embargo policy.

Notification of acceptance:
Notifications of acceptance of the late abstracts will be sent to the presenting author of the abstract by end of April 2023.

Registration and publication of late abstracts:
The presenting author of a late abstract must register for the onsite congress. Until 4 May 2023 the presenting author is offered a special extended “early fee”.
Accepted late abstracts will be published in the online programme, EAACI website and EAACI content platform during the Congress. Publication of the late abstracts as a supplement in the Allergy Journal will be done after the congress. Please note that your late abstract will only be published in the Allergy journal if the late abstract is accepted, uploaded/presented, and the presenting author is registered using the same email address used for abstract submission. In order to have your late abstract published on the website you need to be registered for the congress by 4 May 2023. Kindly note that all abstracts selected for E-TPS Display Only will NOT be published on the EAACI content platform nor in the Allergy Journal.